MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (NASDAQ: HOLX) announces the addition of the Aptima® SARS-CoV-2 assay to its Global Access Initiative (GAI), a program designed to expand access to ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with ...
Minicarm.com: Your Go-To Source for Hologic Fluoroscan Mini C-Arm Sales, Parts & Service HAUPPAUGE, NEW YORK / ACCESS Newswire / February 4, 2025 / Hologic has officially announced the End-of-Sale and ...
Fintel on MSN
Evercore ISI Group downgrades Hologic (HOLX)
Fintel reports that on January 5, 2026, Evercore ISI Group downgraded their outlook for Hologic (NasdaqGS:HOLX) from ...
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the ...
Marlborough medical technology firm Hologic Inc. reported a 74.6% revenue decrease for its COVID-19 related diagnostics testing in its third quarter as compared to last year, indicating a significant ...
Shares of Hologic Inc. HOLX dropped more than 3% in the aftermarket Monday after the medical technology company topped Wall Street estimates for its fiscal third quarter and tweaked its guidance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback